Cargando…

Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology

BACKGROUND: Mounting evidence suggests that soluble oligomers of amyloid-β (oAβ) represent the pertinent synaptotoxic form of Aβ in sporadic Alzheimer’s disease (AD); however, the mechanistic links between oAβ and synaptic degeneration remain elusive. Most in vivo experiments to date have been limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Katherine A, Varghese, Merina, Sowa, Allison, Yuk, Frank, Brautigam, Hannah, Ehrlich, Michelle E, Dickstein, Dara L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210526/
https://www.ncbi.nlm.nih.gov/pubmed/25312309
http://dx.doi.org/10.1186/1750-1326-9-41
_version_ 1782341389697155072
author Price, Katherine A
Varghese, Merina
Sowa, Allison
Yuk, Frank
Brautigam, Hannah
Ehrlich, Michelle E
Dickstein, Dara L
author_facet Price, Katherine A
Varghese, Merina
Sowa, Allison
Yuk, Frank
Brautigam, Hannah
Ehrlich, Michelle E
Dickstein, Dara L
author_sort Price, Katherine A
collection PubMed
description BACKGROUND: Mounting evidence suggests that soluble oligomers of amyloid-β (oAβ) represent the pertinent synaptotoxic form of Aβ in sporadic Alzheimer’s disease (AD); however, the mechanistic links between oAβ and synaptic degeneration remain elusive. Most in vivo experiments to date have been limited to examining the toxicity of oAβ in mouse models that also possess insoluble fibrillar Aβ (fAβ), and data generated from these models can lead to ambiguous interpretations. Our goal in the present study was to examine the effects of soluble oAβ on neuronal and synaptic structure in the amyloid precursor protein (APP) E693Q (“Dutch”) mouse model of AD, which develops intraneuronal accumulation of soluble oAβ with no detectable plaques in AD-relevant brain regions. We performed quantitative analyses of neuronal pathology, including dendrite morphology, spine density, and synapse ultrastructure in individual hippocampal CA1 neurons. RESULTS: When assessing neuronal morphology and complexity we observed significant alterations in apical but not in basal dendritic arbor length in Dutch mice compared to wild type. Moreover, Dutch mice exhibited a significant decrease in dendritic arborization with a decrease in dendritic length and number of intersections at 120 μm and 150 μm from the soma, respectively. We next examined synaptic parameters and found that while there were no differences in overall synaptic structure, Dutch mice displayed a significant reduction in the post-synaptic density (PSD) length of synapses on mushroom spines, in comparison to wild type littermates. CONCLUSION: The structural alterations to individual neurons in Dutch mice along with the changes in larger dendritic spines support the Aβ oligomer hypothesis, which postulates that the early cognitive impairments that occur in AD are attributed to the accumulation of soluble oAβ first affecting at the synaptic level with subsequent structural disturbances and cellular degeneration. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1750-1326-9-41) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4210526
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42105262014-10-29 Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology Price, Katherine A Varghese, Merina Sowa, Allison Yuk, Frank Brautigam, Hannah Ehrlich, Michelle E Dickstein, Dara L Mol Neurodegener Research Article BACKGROUND: Mounting evidence suggests that soluble oligomers of amyloid-β (oAβ) represent the pertinent synaptotoxic form of Aβ in sporadic Alzheimer’s disease (AD); however, the mechanistic links between oAβ and synaptic degeneration remain elusive. Most in vivo experiments to date have been limited to examining the toxicity of oAβ in mouse models that also possess insoluble fibrillar Aβ (fAβ), and data generated from these models can lead to ambiguous interpretations. Our goal in the present study was to examine the effects of soluble oAβ on neuronal and synaptic structure in the amyloid precursor protein (APP) E693Q (“Dutch”) mouse model of AD, which develops intraneuronal accumulation of soluble oAβ with no detectable plaques in AD-relevant brain regions. We performed quantitative analyses of neuronal pathology, including dendrite morphology, spine density, and synapse ultrastructure in individual hippocampal CA1 neurons. RESULTS: When assessing neuronal morphology and complexity we observed significant alterations in apical but not in basal dendritic arbor length in Dutch mice compared to wild type. Moreover, Dutch mice exhibited a significant decrease in dendritic arborization with a decrease in dendritic length and number of intersections at 120 μm and 150 μm from the soma, respectively. We next examined synaptic parameters and found that while there were no differences in overall synaptic structure, Dutch mice displayed a significant reduction in the post-synaptic density (PSD) length of synapses on mushroom spines, in comparison to wild type littermates. CONCLUSION: The structural alterations to individual neurons in Dutch mice along with the changes in larger dendritic spines support the Aβ oligomer hypothesis, which postulates that the early cognitive impairments that occur in AD are attributed to the accumulation of soluble oAβ first affecting at the synaptic level with subsequent structural disturbances and cellular degeneration. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1750-1326-9-41) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-13 /pmc/articles/PMC4210526/ /pubmed/25312309 http://dx.doi.org/10.1186/1750-1326-9-41 Text en © Price et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Price, Katherine A
Varghese, Merina
Sowa, Allison
Yuk, Frank
Brautigam, Hannah
Ehrlich, Michelle E
Dickstein, Dara L
Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
title Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
title_full Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
title_fullStr Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
title_full_unstemmed Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
title_short Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
title_sort altered synaptic structure in the hippocampus in a mouse model of alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210526/
https://www.ncbi.nlm.nih.gov/pubmed/25312309
http://dx.doi.org/10.1186/1750-1326-9-41
work_keys_str_mv AT pricekatherinea alteredsynapticstructureinthehippocampusinamousemodelofalzheimersdiseasewithsolubleamyloidboligomersandnoplaquepathology
AT varghesemerina alteredsynapticstructureinthehippocampusinamousemodelofalzheimersdiseasewithsolubleamyloidboligomersandnoplaquepathology
AT sowaallison alteredsynapticstructureinthehippocampusinamousemodelofalzheimersdiseasewithsolubleamyloidboligomersandnoplaquepathology
AT yukfrank alteredsynapticstructureinthehippocampusinamousemodelofalzheimersdiseasewithsolubleamyloidboligomersandnoplaquepathology
AT brautigamhannah alteredsynapticstructureinthehippocampusinamousemodelofalzheimersdiseasewithsolubleamyloidboligomersandnoplaquepathology
AT ehrlichmichellee alteredsynapticstructureinthehippocampusinamousemodelofalzheimersdiseasewithsolubleamyloidboligomersandnoplaquepathology
AT dicksteindaral alteredsynapticstructureinthehippocampusinamousemodelofalzheimersdiseasewithsolubleamyloidboligomersandnoplaquepathology